Reaction Details |
| Report a problem with these data |
Target | D(2) dopamine receptor |
---|
Ligand | BDBM50176049 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_320895 (CHEMBL872394) |
---|
Ki | 11±n/a nM |
---|
Citation | Smid, P; Coolen, HK; Keizer, HG; van Hes, R; de Moes, JP; den Hartog, AP; Stork, B; Plekkenpol, RH; Niemann, LC; Stroomer, CN; Tulp, MT; van Stuivenberg, HH; McCreary, AC; Hesselink, MB; Herremans, AH; Kruse, CG Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition. J Med Chem48:6855-69 (2005) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
D(2) dopamine receptor |
---|
Name: | D(2) dopamine receptor |
Synonyms: | D(2) dopamine receptor | DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2 | DRD2_HUMAN | Dopamine D2 receptor | Dopamine D2 receptor (D2) | Dopamine D2 receptor (D2R) | Dopamine D2A | Dopamine2-like | d2 |
Type: | Cell-surface receptors |
Mol. Mass.: | 50647.10 |
Organism: | Homo sapiens (Human) |
Description: | P14416 |
Residue: | 443 |
Sequence: | MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVS
REKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTA
SILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQN
ECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPL
KGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPP
SHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSR
RKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSA
VNPIIYTTFNIEFRKAFLKILHC
|
|
|
BDBM50176049 |
---|
n/a |
---|
Name | BDBM50176049 |
Synonyms: | 3-{3-[4-(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-5-methyl-1H-indole | CHEMBL198107 |
Type | Small organic molecule |
Emp. Form. | C24H29N3O2 |
Mol. Mass. | 391.506 |
SMILES | Cc1ccc2[nH]cc(CCCN3CCN(CC3)c3cccc4OCCOc34)c2c1 |
Structure |
|